Aristotle University Of Thessaloniki (AUTH)
Η επίδραση της απώλειας βάρους στα επίπεδα της αντιμυλλεριανής ορμόνης σε υπέρβαρες και παχύσαρκες γυναίκες με το σύνδρομο των πολυκυστικών ωοθηκών
Abstract
dc:descriptionIntroduction-Objective: It has been reported that patients with PCOS have increased serum AMH levels than healthy controls. It has also been reported that LH concentrations correlate with AMH levels, in conditions like polycystic ovary syndrome. This study was designed to investigate the effect of: weight loss with diet, exercise and orlistate or sibutramine administration, on serum AMH levels, in overweight and obese patients with PCOS. Design- Subjects: The study consists of two parts: In the first part, 61 overweight and obese patients with PCOS and 20 overweight and obese non-PCOS women were placed on a diet, exercise plus orlistate, for six months. In the second part, 76 overweight and obese patients with PCOS were patients were placed on a diet), exercise) plus sibutramine, for one month. After randomization with 3 : 1 rate, 57 patients continued the same program for another six months and 19 patients continued only on diet and exercise for the subsequent six months. Blood samples were collected between the 3rd and 7th day of the cycle and the basal serum levels of AMH, FSH, LH, PRL, T, D4A, DHEAS, 17a-OHP, SHBG, glucose, and insulin were measured. The same tests were repeated, at 3rd and 6th month of treatment for the first part of the study and at the 4th and 7th for the second part. Results: In the first part of the study: 1a) BMI was significantly reduced after three and six months of treatment six months of treatment in PCOS, 1b) LH concentrations and AMH levels were higher in PCOS group than in control group in all comparisons and significantly increased only in the PCOS group after three and six months of treatment. In the second part of the study : 2a): patients who received sibutramine for seven months achieved a greater decrease of all anthropometric features compared with the patients who received sibutramine only for the first month of the program, 2b) patients who received sibutramine for seven months achieved a greater decrease of androgen levels and improved all insulin resistance indices compared with the patients who received sibutramine only for the first month, 2c) a significant decrease in AMH levels was noticed in the group of patients who received sibutramine for seven months. Conclusions: 1. Weight loss programs after diet and exercise, in overweight and obese patients with PCOS, achieve a greater weight loss, more pronounced decrease of androgen levels and improvement of insulin resistance indices if sibutramine or orlistate is added in the treatment protocol. 2. Weight loss after diet, exercise and orlistate administration in overweight and obese patients with PCOS, for six months, significantly reduces LH levels, due to a decrease of the fatty tissue, in which a part of androgens is aromatized to estrogens, which in turn inhibit LH secretion.Moreover, a significant increase of AMH levels is observed, supporting further the hypothesis that in PCOS, LH concentrations are associated with AMH levels. 3. Weight loss after diet, exercise and sibutramine administration in overweight and obese patients with PCOS, for seven months, does not affect LH levels and significantly reduces AMH concetrations. These findings suggest that sibutramine has an inhibiting effect on the hypothalamus-pituitary axis and possibly a direct effect on the ovary, reducing AMH production by follicular granoulosa cells.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vosnakis, Christos
- Βοσνάκης, Χρήστος
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28091